These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 35316551)

  • 21. Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases.
    Català A; Muñoz-Santos C; Galván-Casas C; Roncero Riesco M; Revilla Nebreda D; Solá-Truyols A; Giavedoni P; Llamas-Velasco M; González-Cruz C; Cubiró X; Ruíz-Villaverde R; Gómez-Armayones S; Gil Mateo MP; Pesqué D; Marcantonio O; Fernández-Nieto D; Romaní J; Iglesias Pena N; Carnero Gonzalez L; Tercedor-Sanchez J; Carretero G; Masat-Ticó T; Rodríguez-Jiménez P; Gimenez-Arnau AM; Utrera-Busquets M; Vargas Laguna E; Angulo Menéndez AG; San Juan Lasser E; Iglesias-Sancho M; Alonso Naranjo L; Hiltun I; Cutillas Marco E; Polimon Olabarrieta I; Marinero Escobedo S; García-Navarro X; Calderón Gutiérrez MJ; Baeza-Hernández G; Bou Camps L; Toledo-Pastrana T; Guilabert A
    Br J Dermatol; 2022 Jan; 186(1):142-152. PubMed ID: 34254291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
    Martora F; Battista T; Ruggiero A; Scalvenzi M; Villani A; Megna M; Potestio L
    Viruses; 2023 Jun; 15(7):. PubMed ID: 37515110
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines.
    Adjobimey T; Meyer J; Sollberg L; Bawolt M; Berens C; Kovačević P; Trudić A; Parcina M; Hoerauf A
    Front Immunol; 2022; 13():917905. PubMed ID: 35799790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis.
    Shafiee A; Amini MJ; Arabzadeh Bahri R; Jafarabady K; Salehi SA; Hajishah H; Mozhgani SH
    Eur J Med Res; 2023 Aug; 28(1):278. PubMed ID: 37559096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data.
    Primorac Padjen E; Marcec R; Zidar M; Padjen I; Katanec T; Anic B; Likic R
    Rheumatol Int; 2024 Feb; 44(2):273-281. PubMed ID: 38142450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curbing COVID-19 Vaccine Hesitancy from a Dermatological Standpoint: Analysis of Cutaneous Reactions in the Vaccine Adverse Event Reporting System (VAERS) Database.
    Falotico JM; Desai AD; Shah A; Ricardo JW; Lipner SR
    Am J Clin Dermatol; 2022 Sep; 23(5):729-737. PubMed ID: 35931925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of cases of CNS demyelination following COVID-19 vaccination.
    Ismail II; Salama S
    J Neuroimmunol; 2022 Jan; 362():577765. PubMed ID: 34839149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases.
    Shakoei S; Kalantari Y; Nasimi M; Tootoonchi N; Ansari MS; Razavi Z; Etesami I
    Dermatol Ther; 2022 Aug; 35(8):e15651. PubMed ID: 35716105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
    Gronbeck C; Grant-Kels JM
    Clin Dermatol; 2021; 39(4):674-687. PubMed ID: 34809772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical observation and analysis of skin reactions caused by COVID-19 vaccination.
    Li Y; Fan L; Mao Q; Luan X; Wang Z; Zeng N; Cheng Y; Li Y; Xia Q; Lu Z; Lu Q; Min W; Luo D
    Dermatol Ther; 2022 Oct; 35(10):e15746. PubMed ID: 36190010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series.
    Cahuapaza-Gutierrez NL
    Lupus; 2024 Apr; 33(4):375-386. PubMed ID: 38315894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A landscape on disorders following different COVID-19 vaccination: a systematic review of Iranian case reports.
    Sadat Larijani M; Doroud D; Banifazl M; Karami A; Bavand A; Ashrafian F; Ramezani A
    Eur J Med Res; 2023 Nov; 28(1):542. PubMed ID: 38008729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
    Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
    Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of SARS-CoV-2 Vaccination or Infection With Bell Palsy: A Systematic Review and Meta-analysis.
    Rafati A; Pasebani Y; Jameie M; Yang Y; Jameie M; Ilkhani S; Amanollahi M; Sakhaei D; Rahimlou M; Kheradmand A
    JAMA Otolaryngol Head Neck Surg; 2023 Jun; 149(6):493-504. PubMed ID: 37103913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative review on mucocutaneous reactions caused by Covid-19 infection versus Covid-19 vaccination.
    Sadeghi S; Amini Z; Goodarzi A
    Exp Dermatol; 2022 Aug; 31(8):1122-1127. PubMed ID: 35657119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An extremely rare mucocutaneous adverse reaction following COVID-19 vaccination: Toxic epidermal necrolysis.
    Mardani M; Mardani S; Asadi Kani Z; Hakamifard A
    Dermatol Ther; 2022 May; 35(5):e15416. PubMed ID: 35238119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients.
    Pourani MR; Shahidi Dadras M; Salari M; Diab R; Namazi N; Abdollahimajd F
    Dermatol Ther; 2022 Feb; 35(2):e15223. PubMed ID: 34820975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
    Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
    Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.